George Foussias, MD PhD FRCPC
George Foussias, MD PhD FRCPC
Centre for Addiction and Mental Health, University of Toronto
Verified email at
Cited by
Cited by
Negative symptoms in schizophrenia: avolition and Occam's razor
G Foussias, G Remington
Schizophrenia bulletin 36 (2), 359-369, 2010
Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders
G Foussias, O Agid, G Fervaha, G Remington
European Neuropsychopharmacology 24 (5), 693-709, 2014
An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis
O Agid, T Arenovich, G Sajeev, RB Zipursky, S Kapur, G Foussias, ...
Journal of Clinical Psychiatry 72 (11), 1439, 2011
Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia
G Fervaha, G Foussias, O Agid, G Remington
Acta Psychiatrica Scandinavica 130 (4), 290-299, 2014
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
G Fervaha, A Graff-Guerrero, KK Zakzanis, G Foussias, O Agid, ...
Journal of psychiatric research 47 (11), 1590-1596, 2013
Impact of primary negative symptoms on functional outcomes in schizophrenia
G Fervaha, G Foussias, O Agid, G Remington
European Psychiatry 29 (7), 449-455, 2014
Treating negative symptoms in schizophrenia: an update
G Remington, G Foussias, G Fervaha, O Agid, H Takeuchi, J Lee, M Hahn
Current treatment options in psychiatry 3, 133-150, 2016
Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome
G Fervaha, G Foussias, O Agid, G Remington
Schizophrenia research 166 (1-3), 9-16, 2015
Neuroimaging evidence for the deficit subtype of schizophrenia
AN Voineskos, G Foussias, J Lerch, D Felsky, G Remington, TK Rajji, ...
JAMA psychiatry 70 (5), 472-480, 2013
Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits
G Foussias, S Mann, KK Zakzanis, R Van Reekum, O Agid, G Remington
Schizophrenia research 132 (1), 24-27, 2011
Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
A Moros, V Rodriguez, I Saborit-Villarroya, A Montraveta, P Balsas, ...
Leukemia 28 (10), 2049, 2014
Does relapse contribute to treatment resistance? Antipsychotic response in first-vs. second-episode schizophrenia
H Takeuchi, C Siu, G Remington, G Fervaha, RB Zipursky, G Foussias, ...
Neuropsychopharmacology 44 (6), 1036-1042, 2019
Motivational deficits and cognitive test performance in schizophrenia
G Fervaha, KK Zakzanis, G Foussias, A Graff-Guerrero, O Agid, ...
JAMA psychiatry 71 (9), 1058-1065, 2014
Anhedonia in depression and schizophrenia: a transdiagnostic challenge
C Lambert, S Da Silva, AK Ceniti, SJ Rizvi, G Foussias, SH Kennedy
CNS neuroscience & therapeutics 24 (7), 615-623, 2018
Motivational deficits as the central link to functioning in schizophrenia: a pilot study
G Foussias, S Mann, KK Zakzanis, R Van Reekum, G Remington
Schizophrenia Research 115 (2-3), 333-337, 2009
Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls
S Shahab, BH Mulsant, ML Levesque, N Calarco, A Nazeri, AL Wheeler, ...
Neuropsychopharmacology 44 (5), 898-906, 2019
Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?
G Remington, O Agid, G Foussias, L Ferguson, K McDonald, V Powell
Psychopharmacology 225, 505-518, 2013
Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis
AL Wheeler, M Wessa, PR Szeszko, G Foussias, MM Chakravarty, ...
JAMA psychiatry 72 (5), 446-455, 2015
Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification
S Farooq, O Agid, G Foussias, G Remington
Schizophrenia bulletin 39 (6), 1169-1172, 2013
Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
O Agid, G Foussias, G Remington
Expert Opinion on Pharmacotherapy 11 (14), 2301-2317, 2010
The system can't perform the operation now. Try again later.
Articles 1–20